Literature DB >> 12603351

Membrane-bound and releasable nucleotidase activities: differences in canine mesenteric artery and vein.

Janette Bobalova1, Violeta N Mutafova-Yambolieva.   

Abstract

1. At least two enzymatic activities are proposed to degrade the extracellular ATP: (i) ubiquitously expressed membrane-bound enzymes (ecto-nucleotidases); and (ii) soluble (releasable) nucleotidases that are released during stimulation of sympathetic nerves and break down neuronal ATP. No quantitative data have placed the magnitude of these nucleotidase activities into a physiological perspective of neurovascular control. 2. We studied comparatively the membrane-bound and releasable nucleotidase activities in canine isolated inferior mesenteric arteries and veins using 1,N6-etheno(epsilon)-nucleotides (i.e. epsilon-ATP, epsilon-ADP, epsilon-AMP and epsilon-adenosine) as exogenous substrates. The enzymatic activities were estimated by measuring the disappearance of the epsilon-substrate and appearance of epsilon-products by means of HPLC-fluorescence detection during either stimulation of sympathetic perivascular nerves (releasable activity) or in the absence of nerve stimulation (ecto-nucleotidase activity). 3. Incubation of vascular segments with 50 nmol/L epsilon-ATP for 60 min resulted in a decrease of the epsilon-ATP substrate by 63.5 +/- 4.6 and 91.2 +/- 6.2% in the artery and vein, respectively. In contrast, the decrease of the epsilon-ATP during electrical field stimulation (EFS; 16 Hz, 0.3 msec, 2 min) was 39.8 +/- 4.2% in the artery and 13.1 +/- 7.3% in the vein. Therefore, the mesenteric arteries demonstrate a greater releasable ATPase activity and a weaker ecto-ATPase activity than mesenteric veins. 4. The degradation of epsilon-ADP and epsilon-AMP was similar in both blood vessels under either experimental protocol. The epsilon-adenosine was not significantly degraded in the absence or presence of EFS. 5. These data implicate a differential removal of extracellular ATP as a potential mechanism of serving resistance and capacitance in the splanchnic circulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603351     DOI: 10.1046/j.1440-1681.2003.03808.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Adenosine 5-diphosphate-ribose is a neural regulator in primate and murine large intestine along with β-NAD(+).

Authors:  Leonie Durnin; Sung Jin Hwang; Sean M Ward; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

2.  N-type and P/Q-type calcium channels regulate differentially the release of noradrenaline, ATP and beta-NAD in blood vessels.

Authors:  Lisa M Smyth; Ilia A Yamboliev; Violeta N Mutafova-Yambolieva
Journal:  Neuropharmacology       Date:  2008-09-25       Impact factor: 5.250

Review 3.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

4.  Release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD⁺) in the rat brain.

Authors:  Leonie Durnin; Yanping Dai; Isamu Aiba; C William Shuttleworth; Ilia A Yamboliev; Violeta N Mutafova-Yambolieva
Journal:  Eur J Neurosci       Date:  2012-01-25       Impact factor: 3.386

5.  Characterization of the N6-etheno-bridge method to assess extracellular metabolism of adenine nucleotides: detection of a possible role for purine nucleoside phosphorylase in adenosine metabolism.

Authors:  Edwin K Jackson; Delbert G Gillespie; Dongmei Cheng; Zaichuan Mi; Elizabeth V Menshikova
Journal:  Purinergic Signal       Date:  2020-05-04       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.